Pfizer Inc. (BCBA:PFE)

Catalent Statistics

Total Valuation

Pfizer has a market cap or net worth of ARS 186.25 trillion. The enterprise value is 251.70 trillion.

Market Cap	186.25T
Enterprise Value	251.70T

Important Dates

The last earnings date was Tuesday, August 5, 2025.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	Jul 25, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.92%
Shares Change (QoQ)	-0.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.68B

Valuation Ratios

The trailing PE ratio is 14.59 and the forward PE ratio is 8.99.

PE Ratio	14.59
Forward PE	8.99
PS Ratio	2.46
PB Ratio	1.76
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.31, with an EV/FCF ratio of 17.04.

EV / Earnings	19.71
EV / Sales	2.96
EV / EBITDA	7.31
EV / EBIT	10.56
EV / FCF	17.04

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.70.

Current Ratio	1.16
Quick Ratio	0.78
Debt / Equity	0.70
Debt / EBITDA	2.42
Debt / FCF	4.99
Interest Coverage	6.26

Financial Efficiency

Return on equity (ROE) is 12.17% and return on invested capital (ROIC) is 7.18%.

Return on Equity (ROE)	12.17%
Return on Assets (ROA)	5.25%
Return on Invested Capital (ROIC)	7.18%
Return on Capital Employed (ROCE)	10.53%
Revenue Per Employee	935.74M
Profits Per Employee	157.62M
Employee Count	81,000
Asset Turnover	0.30
Inventory Turnover	1.45

Taxes

Income Tax	-279.04B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.18% in the last 52 weeks. The beta is 0.44, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	-12.18%
50-Day Moving Average	7,634.40
200-Day Moving Average	7,617.30
Relative Strength Index (RSI)	58.83
Average Volume (20 Days)	21,722

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.54

Income Statement

In the last 12 months, Pfizer had revenue of ARS 75.80 trillion and earned 12.77 trillion in profits. Earnings per share was 2,248.99.

Revenue	75.80T
Gross Profit	55.95T
Operating Income	21.06T
Pretax Income	12.51T
Net Income	12.77T
EBITDA	29.10T
EBIT	21.06T
Earnings Per Share (EPS)	2,248.99

Balance Sheet

The company has 15.73 trillion in cash and 73.67 trillion in debt, giving a net cash position of -57,939.18 billion.

Cash & Cash Equivalents	15.73T
Total Debt	73.67T
Net Cash	-57,939.18B
Net Cash Per Share	n/a
Equity (Book Value)	105.69T
Book Value Per Share	18,525.32
Working Capital	7.10T

Cash Flow

In the last 12 months, operating cash flow was 18.03 trillion and capital expenditures -3,265.35 billion, giving a free cash flow of 14.77 trillion.

Operating Cash Flow	18.03T
Capital Expenditures	-3,265.35B
Free Cash Flow	14.77T
FCF Per Share	n/a

Margins

Gross margin is 73.82%, with operating and profit margins of 27.78% and 16.84%.

Gross Margin	73.82%
Operating Margin	27.78%
Pretax Margin	16.50%
Profit Margin	16.84%
EBITDA Margin	38.39%
EBIT Margin	27.78%
FCF Margin	19.49%

Dividends & Yields

This stock pays an annual dividend of 354.95, which amounts to a dividend yield of 4.36%.

Dividend Per Share	354.95
Dividend Yield	4.36%
Dividend Growth (YoY)	75.08%
Years of Dividend Growth	3
Payout Ratio	89.68%
Buyback Yield	-0.92%
Shareholder Yield	3.44%
Earnings Yield	6.85%
FCF Yield	7.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on January 24, 2024. It was a forward split with a ratio of 2.

Last Split Date	Jan 24, 2024
Split Type	Forward
Split Ratio	2

Scores

Pfizer has an Altman Z-Score of 2.2 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	8